Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Growth hormone reverses thymic atrophy in HIV-infected men

Aug. 21, 2002

New PPARalpha/delta receptor agonists covered by GSK patent

Aug. 20, 2002

Roche claims novel OSLC inhibitors in recent patent

Aug. 19, 2002

MSI-1436 prevents the homeostatic metabolic response induced by decreased feeding in rats

Aug. 19, 2002

Columbia submits NDA for testosterone buccal bioadhesive product

Aug. 19, 2002

AstraZeneca researchers identify new IBAT inhibitors for dyslipidemic conditions

Aug. 14, 2002

Clearance given for FM-VP4 trial

Aug. 14, 2002

A once-daily dose regimen of NN-2211 found to be feasible for NIDDM

Aug. 14, 2002

Schering-Plough presents new cholesterol-lowering agents

Aug. 13, 2002

New NPY Y5 antagonists in early development at Schering-Plough

Aug. 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...